Skip to main content

Hybrid drug-loaded plasmonic photothermal microneedle patch against skin infections

Project description

Microneedle for nosocomial skin infections

Drug-resistant bacteria cause nosocomial skin infections. New devices are necessary to facilitate local antibiotic delivery and improve drug efficiency. To provide proof-of-concept, the EU-funded HOTSKIN project will assess the technical and commercial feasibility of a device for nosocomial skin infection treatment. This hybrid microneedle patch penetrates difficult-to-infiltrate skin layers to deliver antibiotics and raise the local temperature to enhance drug effectiveness, obviating the need for high dosage systemic drug administration. The device can bolster the use of antibacterial drugs for the topical treatment of skin infections with improved dermatological delivery. HOTSKIN will validate the device’s fabrication process for additional commercial scalability and functionality with nanocarrier-drug complexes and also conduct extensive market analysis.

Host institution

KAROLINSKA INSTITUTET
Net EU contribution
€ 100 000,00
Address
Nobels Vag 5
17177 Stockholm
Sweden

See on map

Region
Östra Sverige Stockholm Stockholms län
Activity type
Higher or Secondary Education Establishments
Other funding
No data

Beneficiaries (2)

KAROLINSKA INSTITUTET
Sweden
Net EU contribution
€ 100 000,00
Address
Nobels Vag 5
17177 Stockholm

See on map

Region
Östra Sverige Stockholm Stockholms län
Activity type
Higher or Secondary Education Establishments
Other funding
No data
KAROLINSKA INSTITUTET HOLDING AB
Sweden
Net EU contribution
€ 50 000,00
Address
Nanna Svartz Väg 6 A
171 65 Solna

See on map

Region
Östra Sverige Stockholm Stockholms län
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
No data